(HealthDay News) – For child survivors of a blood cancer called acute lymphocytic leukemia (ALL), two years of follow-up medications help assure that the cancer doesn’t return. But a new study finds that a quarter of these young cancer survivors aren’t taking the potentially lifesaving drugs. A prime reason for the lapse: […].

READ FULL ARTICLE Curated publisher From Health